Latest News

Keep up-to-date with the latest news, developments and events that are happening at the NIHR Moorfields Biomedical Research Centre.

We actively encourage patients and members of the public to get involved and found recent events to be both successful and valuable.

For more information on up coming events click here

  • 14 Sep 2016

    NIHR Moorfields BRC - Major funding for eye research announced

    NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology has received a major five year funding award for eye research from the National Institute for Health Research (NIHR), recognising the world-leading excellence of our partnership.

    The joint biomedical research centre (BRC) for ophthalmology, based at Moorfields Eye Hospital and the UCL Institute of Ophthalmology, has been awarded £19 million over five years, starting on 1 April 2017. 

    This announcement follows an application to the Department of Health earlier this summer, which was assessed by an international selection panel.

    Professor Sir Peng Tee Khaw, Moorfields’ Director of Research and Development and Director of the BRC, and Director of the UCL Institute of Ophthalmology, Professor Andrew Dick said:

    “We are delighted to once again have been awarded a NIHR Biomedical Research Centre. This substantial investment in eye research will enable us to continue to rapidly develop and deliver life-changing treatments for our patients. With sight loss predicted to double by the year 2050, this vital funding for eye research has never been more important. This award recognises our world-leading excellence in translating basic research through to treatments and improvements for patients.”

    Health Secretary, Jeremy Hunt said:

    “The UK has so often led the world in health research – from the invention of the smallpox vaccine to the discovery of penicillin and the development of DNA sequencing. Today, we are making sure the UK stays ahead of the game by laying the foundations for a new age of personalised medicine. We are supporting the great minds of the NHS to push the frontiers of medical science so that patients in this country continue to benefit from the very latest treatments and the highest standards of care.”

    A new £816 million investment in health research has been shared between 20 NHS and university partnerships across England through the NIHR. Each of the 20 BRCs, of which we are one, will host the development of new, ground-breaking treatments, diagnostics, prevention and care for patients in a wide range of diseases.

    Press Release from the Department of Health - New £816 million investment in health research

    Adapted from Moorfields Eye Hospital press release - Link

  • 22 Aug 2016

    NIHR Moorfields BRC Researchers Publish First Co-authored Paper with a Patient

    The NIHR Moorfields BRC is delighted to announce that researchers at Moorfields Eye Hospital and the Institute of Ophthalmology have published their first co-authored paper with a patient. The paper is entitled, ‘Psychophysical measures of visual function and everyday perceptual experience in a case of congenital stationary night blindness’.

    By collecting data from a series of filmed interviews, the paper focuses on the experiences of a 78 year old patient diagnosed with congenital stationary night blindness. The study demonstrates how a rich description from a patient can be complementary to the scientific measurements and tests conducted in the hospital. Capturing both sets of data from a patient’s eye condition diagnosis helps to build a better and more complete understanding of the experience of vision loss.

    The full paper can be found by clicking here

  • 12 Jul 2016

    NIHR New Media Competition Award – ‘Partnership for Sight’

    The NIHR has announced the short film ‘Partnership for Sight’ as the winner of its 2016 New Media Competition.

    Partnership for Sight was created by NIHR Clinical Lecturer Dr Mariya Moosajee with her team of researchers at Moorfields Eye Hospital and the UCL Institute of Ophthalmology and explains the team’s research into stem cell therapy for genetic eye disease. The film is narrated by Matthew Murrell, a patient who has been involved in informing the direction of the team’s research.

    On winning the NIHR New Media Competition, Dr Moosajee said:
    “I am absolutely thrilled to hear that the public and NIHR have awarded my team this prize. Losing your sight is one of the most feared health outcomes with an enormous impact on the individual and their family’s day-to-day life. Patients with genetic eye disease face this future with no treatment available to them. This prize highlights that the public understand the importance of research into blinding conditions and the positive impact it can have on quality of life. I am so pleased to be able to work with patients and give them hope for the future.”

    The film previously won the third round of the ‘Communicating Research Competition’ held by the NIHR Moorfields BRC in 2015. More background information about the video can be found on the Communicating Research Competition webpage.

    The annual NIHR New Media Competition invites researchers to raise awareness of their work through video to communicate their research and its impact on patients. For more information about this year’s National Institute for Health Research New Media Competition, please click here

  • 29 Jun 2016

    Retina Day 2015 Wins UCL Award for Communications Excellence

    The Communication Excellence Awards were held by the UCL Faculty of Brain Sciences on 29th June 2016. By demonstrating best practice and giving practical advice, the event aimed to empower faculty staff to use new and innovative communication methods to connect with audiences.

    The event finished with an awards ceremony to recognise and celebrate the work of faculty staff who have demonstrated these new and innovative communication methods. Dr Andi Skilton, a communications manager at the UCL Institute of Ophthalmology and member of the PPI team at NIHR Moorfields BRC, was recognised for his work on the Retina Day in 2015 which won the Public Engagement category of the Faculty of Brain Sciences Communications Excellence Awards.

    The Retina Day was a free one-day event for patients with inherited retinal diseases to meet with clinicians, charities and researchers, and learn more about ongoing research. 

    Click here for more information about the Communication Excellence Awards.

    Click here for more information about Retina Day 2015. 

  • 25 May 2016

    PPI training opportunities - UCL Hospitals Biomedical Research Centre

    The National Institute for Health Research University College London Hospitals Biomedical Research Centre, the Wellcome Trust and UCLPartners are running a programme of workshops for clinical academic researchers on patient and public involvement (PPI) in research.

    These workshops are open to researchers working in UCLPartners partnership organisations and aim to build up researchers’ skills in effectively involving lay people in the research process, from setting research priorities to designing protocols. Each workshop is aimed at a different experience level of PPI - 'beginners only', 'experienced only' and 'all experience levels'

    To book a place, please contact the PPI Helpdesk stating which workshop, the date, your name, job title and organisation. A maximum of two courses can be booked per person. There is no charge for attending a course, however we reserve the right to charge a £50 non-attendance fee if you fail to inform us 24 hours before the workshop that you won’t be attending.

    For more information and a full list of the scheduled workshops being held between May and December 2016, please click here.

  • 20 May 2016

    Clinical Research Facility - Open Day 2016

    Find out more about clinical research at the CRF open day.

    Moorfields NIHR Clinical Research Facility (CRF) is hosting an open day on Friday 20th May 2016 to mark International Clinical Trials Day which commemorates the day that Scottish physician James Lind began his trials into the causes of scurvy.

    Members of the public can meet our team in the CRF for interactive workshops discussing general eye health, the importance of our eyes, vision research and current clinical trials from 9.30am onwards.

    Then a series of guest speakers will be offering various insights into their pioneering research between 11.30am-1pm. There will also be an opportunity to ask any questions and refreshments will be provided on the day.

    Moorfields CRF open day aims to raise awareness of better clinical research, and educational activities will explore the role of clinical research in improving outcomes for patients with eye diseases.

    This is a free event and you can register your interest by emailing or just come along on the day!

    CRF Open Day

  • 15 Mar 2016

    What is epidemiological analysis?

    Catey Bunce, Principal Statistician at the NIHR Moorfields Biomedical Research Centre and Richard Wormald, a Consultant Ophthalmologist at Moorfields Eye Hospital, have both written an article on the topic of registration for sight impairment. This article is published in Digest, which is the Macular Society’s annual round up of AMD research news.

    This article outlines the steps of registering and certifying visually impaired people and significantly focuses on why epidemiological analysis is part of the CVI process.

    Epidemiology, in this context, is ‘the study of the distribution and causes of sight impairment’. Studying data captured during the certification/registration process means that important facts about individuals with sight impairment can be determined and this can be fed back to those who are charged with providing support to people with the condition.

    More information on the certification/registration process and the epidemiological analysis can be found on page 64 of the 2016 edition of Digest.

  • 7 Mar 2016

    AWARE for All - Clinical Research Education Day

    On Monday, 7 March 2016 CISCRP will be holding its first AWARE for All Clinical Research Education Day in the United Kingdom. In partnership with EUPATI, European Patients Academy on Therapeutic Innovation, this exciting program will bring together a variety of London-based health and research organizations, hospitals, local patients and members of the general public to learn about clinical research.

    AWARE for All is an educational program free and open to the public for the purpose of providing information to help people make informed decisions about clinical research participation. Since 2003, AWARE for All Clinical Research Education Day has been offered over 45 times in cities across the US, and CISCRP are enthusiastic to expand our outreach to the UK. CISCRP has teamed with research and community partners to provide quality speakers and information on clinical research, and nearly 100% of the 6500+ attendees have rated the program as excellent and highly informative. The program will feature free health checks, an Information Alley/Exhibit Area, meaningful presentations from prominent UK-based medical professionals and community patients, as well as free food and giveaways.

    To register for this event or for more information, please click here.

    The AWARE for All flyer can be downloaded by clicking here: PDF iconAware for All Flyer.pdf

  • 29 Jan 2016

    Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013 - out in Eye!

    The two statisticians of our PPI team, Catey Bunce and Ana Quartilho, are co-authors of a recently published paper updating the figures of sight impairment causes in England and Wales between April 2012 and March 2013. The last complete report on causes of blindness in England and Wales was for data collected during 1 April 2007 and 31 March 2008.

    The data analysed for this paper is from the 24,009 registrations that were known of between this period. Of which, 10,410 were for severe sight impairment registrations.

    The results of this analysis showed that:

    • The numbers of CVIs are slightly higher than those observed in April 2007–March 2008.
    • The ratio of severe sight impairment and the other registrations has remained the same.
    • The proportion of certificates without a single main cause has fallen slightly.
    • Glaucoma remains the second most common cause of registrations but hereditary retinal disorders overtook diabetes as third leading cause of serve sight impairment registrations.
    • AMD is still by far the leading cause of certifications for sight impairment in England and Wales.

    The abstract and full paper can be found by clicking here.